Venous thromboembolism and the pill. The WHO technical report on cardiovascular disease and steroid hormone contraception: State-of-the-art

Human Reproduction

Volumn 13, Issue 11, 1998, Pages 2981-2983

  Helmerhorst, Frans M ^a   Rosendaal, Frits R ^a   Vandenbroucke, Jan P ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATED PROTEIN C; CONTRACEPTIVE AGENT; ESTROGEN; ETHINYLESTRADIOL; GESTAGEN; STEROID;

ACUTE HEART INFARCTION; CARDIOVASCULAR DISEASE; CONTRACEPTION; HUMAN; OBESITY; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; SHORT SURVEY; SMOKING; STROKE; THROMBOEMBOLISM; VEIN THROMBOSIS; WORLD HEALTH ORGANIZATION;

EID: 0031781359     PISSN: 02681161     EISSN: None     Source Type: Journal    
DOI: 10.1093/humrep/13.11.2981     Document Type: Short Survey

References (19)

1. Benagiano, G. (1998) Learning from the past, venous thromboembolism and the pill: an endless saga. (1998) Hum. Reprod., 13, 1115-1116.
2. Cohen, J. (1998) Recommendations on the safety of oral contraceptives are too important for the regulating agencies alone. Hum. Reprod., 13, 1116-1117.
3. de Bruijn, S.F.T.M., Stam, J. and Vandenbroucke, J.P. (1998) Increased risk of cerebral venous sinus thrombosis with third-generation oral contraceptives. Lancet, 351, 1404.
4. Farley, T.M.M., Collins, J. and Schlesselmann, J.J. (1998) Hormonal contraception and risk of cardiovascular disease: an international perspective. Contraception, 57, 211-230.
5. Hannaford, P. (1998) The collection and interpretation of epidemiological data about the cardiovascular risks associated with the use of steroid contraceptives. Contraception, 57, 137-142.
6. Helmerhorst, F.M., Bloemenkamp, K.W.M., Rosendaal, F.R. and Vandenbroucke, J.P. (1997) Oral contraceptives and thrombotic disease: risk of venous thromboembolism. Thromb. Haem., 78, 327-333.
7. Helmerhorst, F.M., Rosendaal, F.R. and Vandenbroucke, J.P. (1998) The pill and venous thromboembolism: a disarray of several layers of debate. Hum. Reprod., 13, 1119-1120.
8. Jordan, W.M. (1961) Pulmonary embolism. Lancet, ii, 1146-1147.
9. Jick, S.S., Vasilakis, C. and Jick, H. (1998) Pregnancies and terminations after 1995 warning about third-generation oral contraceptives. Lancet, 351, 1404-1405.
10. Kaper, R.F. (1998) Learning from the past: an essential need. Hum. Reprod., 13, 1120.
11. Leader, A. (1998) Incomplete compensation folowing the ban on third generation oral contracptives. Hum. Reprod., 13, 1118.
12. Meirik, O. (1998a) Cardiovascular safety and combined oral contraceptives. Contraception, 57, 135-136.
13. Meirik, O. (1998b) Risks of oral contraceptives. Lancet, 351, 521.
14. Spitzer, W.O. (1997) Balanced view of risks of oral contraceptive. Lancet, 350, 1566-1567.
15. Spitzer, W.O. (1998) Thromboembolism and the pill: the saga must end. Hum. Reprod., 13, 1117-1118.
16. Vandenbroucke, J.P., Helmerhorst, F.M., Bloemenkamp, K.W.M. and Rosendaal, F.R. (1997) Third generation oral contraceptives and deep venous thrombosis: from epidemiologic controversy to new insights in coagulation. Am. J. Obstet. Gynecol., 177, 887-891.
17. Walker, A.M. (1998) Newer oral contraceptives and the risk of venous thromboembolism. Contraception, 57, 169-181.
18. World Health Organization (1997) Scientific Group Meeting on Cardiovascular Disease and Steroid Hormone Contraceptives: summary of conclusions. Wkly Epidemiol. Rec., 72, 361-363.
19. World Health Organization (1998) Cardiovascular Disease and Steroid Hormone Contraception. WHO Technical Report Series, no 877. Geneva, Switzerland.